Elisabeth Lindner,Helena Cowley,Aaron Cowley,Maria Akerman
申请号：
US14902484
公开号：
US10125176B2
申请日:
2014.07.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
